Farhadi Ali, Abuei Haniyeh, Okhovat Mohammad Ali, Geramizadeh Bita, Behzad-Behbahani Abbas, Chong Pei Pei, Nikouyan Negin, Namdari Sepide
Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Medical Laboratory Sciences, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Cancer Cell Int. 2023 Aug 11;23(1):166. doi: 10.1186/s12935-023-03011-8.
There exists strong evidence that human papillomavirus (HPV) is associated with cervical cancer (CC). HPV E6 is a major oncogene whose sequence variations may be associated with the development of CC. There is not sufficient data on the distribution of HPV types in ThinPrep cytology specimens and HPV 16/18 E6 gene variations among CC patients in the southwest of Iran. This study was conducted to contribute to HPV screening and vaccination in Iran.
A total of 648 women screened for cervicitis, intraepithelial neoplasia or CC were included in the study. All participants underwent ThinPrep cytology testing, single-step HPV DNA detection and allele-specific reverse hybridization assays. Moreover, a total of 96 specimens previously tested positive for single infection with HPV16 or 18 were included for variant analysis. HPV16/18 lineages and sublineages were determined by PCR assays followed by sequencing the E6 gene and the construction of neighbor-joining phylogenetic trees.
Overall, HPV DNA was detected in 62.19% of all the screened subjects. The detection rates of HPV DNA among individuals with normal, ASC-US, ASC-H, LSIL, and HSIL cervical cytology were 48.9%, 93.6%, 100%, 100%, and 100%, respectively. Low-risk HPVs were detected more frequently (46.9%) than high-risk (38.9%) and possible high-risk types (11.1%). Of 403 HPV-positive subjects, 172 (42.7%) had single HPV infections while the remaining 231 (57.3%) were infected with multiple types of HPV. Our results indicated a remarkable growth of high-risk HPV66 and 68 and low-risk HPV81 which have rarely been reported in Iran and HPV90 and 87 that are reported for the first time in the country. In addition, 3 lineages (A, D, and C) and 6 sublineages (A1, A2, A4, C1, D1, and D2) of HPV16, and one lineage and 4 sublineages (A1, A3, A4, and A5) of HPV18 were identified. The studied HPV16 and 18 variants mainly belonged to the D1 and A4 sublineages, respectively.
The present study suggests that the prevalence of HPV infection in women of all age groups with or without premalignant lesions in the southwestern Iran is high and the predominant HPV types in the southwest of Iran may differ from those detected in other parts of the country. This study also highlights the necessity of not only initiating HPV vaccination for the general population but also developing new vaccines that confer immunity against the prevalent HPV types in the area and national cervical screening programs using a combination of thinPrep cytology test and HPV detection assays in order to improve the accuracy of the screening.
有强有力的证据表明,人乳头瘤病毒(HPV)与宫颈癌(CC)相关。HPV E6是一种主要的致癌基因,其序列变异可能与CC的发生发展有关。关于伊朗西南部ThinPrep细胞学标本中HPV类型的分布以及CC患者中HPV 16/18 E6基因变异的数据不足。本研究旨在为伊朗的HPV筛查和疫苗接种提供帮助。
本研究共纳入648名因宫颈炎、上皮内瘤变或CC而接受筛查的女性。所有参与者均接受了ThinPrep细胞学检测、单步HPV DNA检测和等位基因特异性反向杂交检测。此外,共纳入96份先前检测为HPV16或18单感染阳性的标本进行变异分析。通过PCR检测确定HPV16/18谱系和亚谱系,随后对E6基因进行测序并构建邻接法系统发育树。
总体而言,在所有筛查对象中,62.19%检测到HPV DNA。宫颈细胞学正常、意义不明确的非典型鳞状细胞(ASC-US)、非典型鳞状细胞不排除高度病变(ASC-H)、低度鳞状上皮内病变(LSIL)和高度鳞状上皮内病变(HSIL)个体中HPV DNA的检出率分别为48.9%、93.6%、100%、100%和100%。低风险HPV的检出频率(46.9%)高于高风险HPV(38.9%)和可能的高风险类型(11.1%)。在403名HPV阳性受试者中,172名(42.7%)为单一HPV感染,其余231名(57.3%)感染了多种类型的HPV。我们的结果表明,高风险HPV66和68以及低风险HPV81显著增加,这两种HPV在伊朗很少被报道,而HPV90和87是在该国首次被报道。此外,鉴定出HPV16的3个谱系(A、D和C)和6个亚谱系(A1、A2、A4、C1、D1和D2),以及HPV18的1个谱系和4个亚谱系(A1、A3、A4和A5)。所研究的HPV16和18变异体主要分别属于D1和A4亚谱系。
本研究表明,伊朗西南部所有年龄组有或无前体病变的女性中HPV感染率较高,伊朗西南部主要的HPV类型可能与该国其他地区检测到的不同。本研究还强调了不仅要为普通人群启动HPV疫苗接种,还要开发针对该地区流行HPV类型的新疫苗以及使用ThinPrep细胞学检测和HPV检测相结合的方法开展国家宫颈筛查项目以提高筛查准确性的必要性。